Sanofi SNY and partner Regeneron REGN announced that the FDA approved Dupixent (dupilumab) for the treatment of chronic ...

Children with inflammatory skin diseases are at an increased risk for sleep and psychological disorders, prompting clinicians ...

A panelist discusses how real-world data presented at the 2025 American Academy of Dermatology Annual Meeting (AAD 2025) ...

Skin and subcutaneous diseases account for 44.84 million DALYs globally in 2021, ranking seventh in disability burden.